6561 POSTER Updated Survival and Safety Data From RADIANT-3 – a Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Trial of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumours (pNET)
Lombard-Bohas, C., Van Cutsem, E., Capdevila, J., de Vries, E.G.E., Tomassetti, P., Lincy, J., Winkler, R.E., Hobday, T., Pommier, R., Yao, J.C.Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)71872-X
Date:
September, 2011
File:
PDF, 43 KB
english, 2011
File converter
More search results
More benefits 
